We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $102M
1-Year Est. Return 0.13%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+0.13%
3 Year Est. Return
-0.09%
5 Year Est. Return
-7.67%
10 Year Est. Return
–
AUM
$39.4M
AUM Growth
-$54.1M
Cap. Flow
-$41.6M
Cap. Flow %
-105.57%
Top 10 Hldgs %
95.65%
Holding
123
New
16
Increased
1
Reduced
3
Closed
94

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$714K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$462K
3
BHC icon
Bausch Health
BHC
+$222K
4
THC icon
Tenet Healthcare
THC
+$194K
5
BLUE
bluebird bio
BLUE
+$174K

Top Sells

Rank Stock Value
1
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.71M
2
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$1.19M
3
OFIX icon
Orthofix Medical
OFIX
+$996K
4
ESRX
Express Scripts Holding Company
ESRX
+$648K
5
EW icon
Edwards Lifesciences
EW
+$640K

Sector Composition

Rank Sector Weight
1 Healthcare 17.09%
2 Consumer Discretionary 0.45%
3 Communication Services 0%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASRT
26
DELISTED
Assertio
ASRT
– –
-375
Closed -$424K
ATRC icon
27
AtriCure
ATRC
$1.89B
– –
-14,000
Closed -$307K
BOX icon
28
Box
BOX
$4.18B
– –
-10,000
Closed -$126K
CALX icon
29
Calix
CALX
$2.32B
– –
-35,000
Closed -$273K
CIEN icon
30
Ciena
CIEN
$53.4B
– –
-10,000
Closed -$207K
CSIQ icon
31
Canadian Solar
CSIQ
$936M
– –
-7,500
Closed -$125K
CYBR
32
DELISTED
CyberArk
CYBR
– –
-5,000
Closed -$251K
DGII icon
33
Digi International
DGII
$2.55B
– –
-25,000
Closed -$295K
DQ
34
Daqo New Energy
DQ
$815M
– –
-25,000
Closed -$80K
EGHT icon
35
8x8 Inc
EGHT
$262M
– –
-30,000
Closed -$248K
ENPH icon
36
Enphase Energy
ENPH
$5.01B
– –
-25,000
Closed -$93K
EW icon
37
Edwards Lifesciences
EW
$47.8B
– –
-27,000
Closed -$640K
EXTR icon
38
Extreme Networks
EXTR
$3.92B
– –
-50,000
Closed -$168K
FN icon
39
Fabrinet
FN
$16.9B
– –
-20,000
Closed -$367K
GPRO icon
40
GoPro
GPRO
$119M
– –
-10,000
Closed -$312K
IBB icon
41
iShares Biotechnology ETF
IBB
$9.44B
– –
-4,800
Closed -$485K
JD icon
42
JD.com
JD
$41.8B
– –
-10,000
Closed -$261K
KN icon
43
Knowles
KN
$3.2B
– –
-15,000
Closed -$276K
LITE icon
44
Lumentum
LITE
$55.4B
– –
-12,500
Closed -$212K
MOH icon
45
Molina Healthcare
MOH
$10.4B
– –
-6,500
Closed -$448K
MRVL icon
46
Marvell Technology
MRVL
$170B
– –
-10,000
Closed -$91K
MXL icon
47
MaxLinear
MXL
$5.88B
– –
-12,500
Closed -$156K
MYGN icon
48
Myriad Genetics
MYGN
$515M
– –
-5,500
Closed -$206K
NBIX icon
49
Neurocrine Biosciences
NBIX
$17.7B
– –
-8,000
Closed -$318K
NTRA icon
50
Natera
NTRA
$37B
– –
-10,528
Closed -$114K
1
2
3 4 5

Similar funds

LIC
Laurus Investment Counsel Toronto, Canada $102M AUM 0% 1-Year Est. Return
SAM
Stembrook Asset Management Red Bank, New Jersey $102M AUM
FHM
Framtiden Holdings Management Chicago, Illinois $102M AUM
IOOF
Independent Order of Foresters Toronto, Ontario, Canada $102M AUM 16.7% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
MBAML
Marble Bar Asset Management LLP London $102M AUM
BHFP
Blom & Howell Financial Planning Modesto, California $102M AUM
RHCA
Rosenthal Henry Capital Advisors Mishawaka, Indiana $102M AUM 15.41% 1-Year Est. Return

Piper Sandler & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Piper Sandler & Co held 123 positions worth $39.4M, down 58% from $93.5M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Piper Sandler & Co withdrew a net $41.6M in Q4 2015, closing 94 positions and reducing 3 holdings. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Piper Sandler & Co opened a new position in Teva Pharmaceuticals worth $759K.

  • Piper Sandler & Co's largest Q4 2015 buy was Teva Pharmaceuticals: 11,559 shares worth $759K.
  • Piper Sandler & Co's biggest Q4 2015 reduction was vTv Therapeutics, cutting an estimated $626K.
  • Piper Sandler & Co fully exited ProShares UltraPro Short S&P 500 in Q4 2015, selling an estimated $1.71M.
  • Piper Sandler & Co's ten largest holdings make up 96% of its $39.4M portfolio in Q4 2015.
  • Piper Sandler & Co opened 16 new positions and closed 94 in Q4 2015.
  • Piper Sandler & Co's portfolio value fell 58% quarter-over-quarter to $39.4M.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.